Global Mumps Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
This report provides a deep insight into the global Mumps Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mumps Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mumps Vaccine market in any manner.
Global Mumps Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MedImmune
Johnson & Johnson
Merck & Co.
Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec
Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax
Inc.
Novartis
Sinovac Biotech
Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Sharp & Dohme Corp
Bionity
Market Segmentation (by Type)
Child
Adult
Market Segmentation (by Application)
Hospitals Pharmacies
Retail Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Mumps Vaccine Market
Overview of the regional outlook of the Mumps Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mumps Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
This report provides a deep insight into the global Mumps Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mumps Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mumps Vaccine market in any manner.
Global Mumps Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
MedImmune
Johnson & Johnson
Merck & Co.
Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec
Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax
Inc.
Novartis
Sinovac Biotech
Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Sharp & Dohme Corp
Bionity
Market Segmentation (by Type)
Child
Adult
Market Segmentation (by Application)
Hospitals Pharmacies
Retail Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Mumps Vaccine Market
Overview of the regional outlook of the Mumps Vaccine Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Mumps Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Mumps Vaccine
1.2 Key Market Segments
1.2.1 Mumps Vaccine Segment by Type
1.2.2 Mumps Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL MUMPS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Mumps Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Mumps Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL MUMPS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Mumps Vaccine Product Life Cycle
3.3 Global Mumps Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Mumps Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mumps Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Mumps Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Mumps Vaccine Market Competitive Situation and Trends
3.8.1 Mumps Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Mumps Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MUMPS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Mumps Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MUMPS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Mumps Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Mumps Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL MUMPS VACCINE MARKET BY REGION
6.1 Global Mumps Vaccine Market Size by Region
6.1.1 Global Mumps Vaccine Market Size by Region
6.1.2 Global Mumps Vaccine Market Size Market Share by Region
6.2 Global Mumps Vaccine Sales by Region
6.2.1 Global Mumps Vaccine Sales by Region
6.2.2 Global Mumps Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Mumps Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Mumps Vaccine Market Size by Type
7.3 North America Mumps Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Mumps Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Mumps Vaccine Market Size by Type
8.3 Europe Mumps Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Mumps Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Mumps Vaccine Market Size by Type
9.3 Asia-Pacific Mumps Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Mumps Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Mumps Vaccine Market Size by Type
10.3 South America Mumps Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Mumps Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Mumps Vaccine Market Size by Type
11.3 Middle East and Africa Mumps Vaccine Market Size by Application
12 MUMPS VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of Mumps Vaccine by Region(2020-2025)
12.2 Global Mumps Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Mumps Vaccine Production
12.4.1 North America Mumps Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Mumps Vaccine Production
12.5.1 Europe Mumps Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Mumps Vaccine Production (2020-2025)
12.6.1 Japan Mumps Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Mumps Vaccine Production (2020-2025)
12.7.1 China Mumps Vaccine Production Growth Rate (2020-2025)
12.7.2 China Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 MUMPS VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Mumps Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Mumps Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Mumps Vaccine Price by Type (2020-2033)
14 MUMPS VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Mumps Vaccine Market Sales by Application (2020-2033)
14.3 Global Mumps Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 MedImmune
15.1.1 MedImmune Basic Information
15.1.2 MedImmune Mumps Vaccine Product Overview
15.1.3 MedImmune Mumps Vaccine Product Market Performance
15.1.4 MedImmune Business Overview
15.1.5 MedImmune SWOT Analysis
15.1.6 MedImmune Recent Developments
15.2 Johnson and Johnson
15.2.1 Johnson and Johnson Basic Information
15.2.2 Johnson and Johnson Mumps Vaccine Product Overview
15.2.3 Johnson and Johnson Mumps Vaccine Product Market Performance
15.2.4 Johnson and Johnson Business Overview
15.2.5 Johnson and Johnson SWOT Analysis
15.2.6 Johnson and Johnson Recent Developments
15.3 Merck and Co.
15.3.1 Merck and Co. Basic Information
15.3.2 Merck and Co. Mumps Vaccine Product Overview
15.3.3 Merck and Co. Mumps Vaccine Product Market Performance
15.3.4 Merck and Co. Business Overview
15.3.5 Merck and Co. SWOT Analysis
15.3.6 Merck and Co. Recent Developments
15.4 Inc.
15.4.1 Inc. Basic Information
15.4.2 Inc. Mumps Vaccine Product Overview
15.4.3 Inc. Mumps Vaccine Product Market Performance
15.4.4 Inc. Business Overview
15.4.5 Inc. Recent Developments
15.5 Sanofi
15.5.1 Sanofi Basic Information
15.5.2 Sanofi Mumps Vaccine Product Overview
15.5.3 Sanofi Mumps Vaccine Product Market Performance
15.5.4 Sanofi Business Overview
15.5.5 Sanofi Recent Developments
15.6 Serum Institute of India
15.6.1 Serum Institute of India Basic Information
15.6.2 Serum Institute of India Mumps Vaccine Product Overview
15.6.3 Serum Institute of India Mumps Vaccine Product Market Performance
15.6.4 Serum Institute of India Business Overview
15.6.5 Serum Institute of India Recent Developments
15.7 Bavarian Nordic
15.7.1 Bavarian Nordic Basic Information
15.7.2 Bavarian Nordic Mumps Vaccine Product Overview
15.7.3 Bavarian Nordic Mumps Vaccine Product Market Performance
15.7.4 Bavarian Nordic Business Overview
15.7.5 Bavarian Nordic Recent Developments
15.8 Astellas Pharma India
15.8.1 Astellas Pharma India Basic Information
15.8.2 Astellas Pharma India Mumps Vaccine Product Overview
15.8.3 Astellas Pharma India Mumps Vaccine Product Market Performance
15.8.4 Astellas Pharma India Business Overview
15.8.5 Astellas Pharma India Recent Developments
15.9 CSL Limited
15.9.1 CSL Limited Basic Information
15.9.2 CSL Limited Mumps Vaccine Product Overview
15.9.3 CSL Limited Mumps Vaccine Product Market Performance
15.9.4 CSL Limited Business Overview
15.9.5 CSL Limited Recent Developments
15.10 Emergent BioSolutions
15.10.1 Emergent BioSolutions Basic Information
15.10.2 Emergent BioSolutions Mumps Vaccine Product Overview
15.10.3 Emergent BioSolutions Mumps Vaccine Product Market Performance
15.10.4 Emergent BioSolutions Business Overview
15.10.5 Emergent BioSolutions Recent Developments
15.11 GlaxoSmithKline
15.11.1 GlaxoSmithKline Basic Information
15.11.2 GlaxoSmithKline Mumps Vaccine Product Overview
15.11.3 GlaxoSmithKline Mumps Vaccine Product Market Performance
15.11.4 GlaxoSmithKline Business Overview
15.11.5 GlaxoSmithKline Recent Developments
15.12 Panacea Biotec
15.12.1 Panacea Biotec Basic Information
15.12.2 Panacea Biotec Mumps Vaccine Product Overview
15.12.3 Panacea Biotec Mumps Vaccine Product Market Performance
15.12.4 Panacea Biotec Business Overview
15.12.5 Panacea Biotec Recent Developments
15.13 Ltd.
15.13.1 Ltd. Basic Information
15.13.2 Ltd. Mumps Vaccine Product Overview
15.13.3 Ltd. Mumps Vaccine Product Market Performance
15.13.4 Ltd. Business Overview
15.13.5 Ltd. Recent Developments
15.14 Biological E Limited
15.14.1 Biological E Limited Basic Information
15.14.2 Biological E Limited Mumps Vaccine Product Overview
15.14.3 Biological E Limited Mumps Vaccine Product Market Performance
15.14.4 Biological E Limited Business Overview
15.14.5 Biological E Limited Recent Developments
15.15 Bharat Biotech Ltd.
15.15.1 Bharat Biotech Ltd. Basic Information
15.15.2 Bharat Biotech Ltd. Mumps Vaccine Product Overview
15.15.3 Bharat Biotech Ltd. Mumps Vaccine Product Market Performance
15.15.4 Bharat Biotech Ltd. Business Overview
15.15.5 Bharat Biotech Ltd. Recent Developments
15.16 Novavax
15.16.1 Novavax Basic Information
15.16.2 Novavax Mumps Vaccine Product Overview
15.16.3 Novavax Mumps Vaccine Product Market Performance
15.16.4 Novavax Business Overview
15.16.5 Novavax Recent Developments
15.17 Inc.
15.17.1 Inc. Basic Information
15.17.2 Inc. Mumps Vaccine Product Overview
15.17.3 Inc. Mumps Vaccine Product Market Performance
15.17.4 Inc. Business Overview
15.17.5 Inc. Recent Developments
15.18 Novartis
15.18.1 Novartis Basic Information
15.18.2 Novartis Mumps Vaccine Product Overview
15.18.3 Novartis Mumps Vaccine Product Market Performance
15.18.4 Novartis Business Overview
15.18.5 Novartis Recent Developments
15.19 Sinovac Biotech
15.19.1 Sinovac Biotech Basic Information
15.19.2 Sinovac Biotech Mumps Vaccine Product Overview
15.19.3 Sinovac Biotech Mumps Vaccine Product Market Performance
15.19.4 Sinovac Biotech Business Overview
15.19.5 Sinovac Biotech Recent Developments
15.20 Ltd.
15.20.1 Ltd. Basic Information
15.20.2 Ltd. Mumps Vaccine Product Overview
15.20.3 Ltd. Mumps Vaccine Product Market Performance
15.20.4 Ltd. Business Overview
15.20.5 Ltd. Recent Developments
15.21 Incepta Vaccine Limited
15.21.1 Incepta Vaccine Limited Basic Information
15.21.2 Incepta Vaccine Limited Mumps Vaccine Product Overview
15.21.3 Incepta Vaccine Limited Mumps Vaccine Product Market Performance
15.21.4 Incepta Vaccine Limited Business Overview
15.21.5 Incepta Vaccine Limited Recent Developments
15.22 Valneva SE
15.22.1 Valneva SE Basic Information
15.22.2 Valneva SE Mumps Vaccine Product Overview
15.22.3 Valneva SE Mumps Vaccine Product Market Performance
15.22.4 Valneva SE Business Overview
15.22.5 Valneva SE Recent Developments
15.23 VBI Vaccines
15.23.1 VBI Vaccines Basic Information
15.23.2 VBI Vaccines Mumps Vaccine Product Overview
15.23.3 VBI Vaccines Mumps Vaccine Product Market Performance
15.23.4 VBI Vaccines Business Overview
15.23.5 VBI Vaccines Recent Developments
15.24 PT Bio Farma
15.24.1 PT Bio Farma Basic Information
15.24.2 PT Bio Farma Mumps Vaccine Product Overview
15.24.3 PT Bio Farma Mumps Vaccine Product Market Performance
15.24.4 PT Bio Farma Business Overview
15.24.5 PT Bio Farma Recent Developments
15.25 Sharp and Dohme Corp
15.25.1 Sharp and Dohme Corp Basic Information
15.25.2 Sharp and Dohme Corp Mumps Vaccine Product Overview
15.25.3 Sharp and Dohme Corp Mumps Vaccine Product Market Performance
15.25.4 Sharp and Dohme Corp Business Overview
15.25.5 Sharp and Dohme Corp Recent Developments
15.26 Bionity
15.26.1 Bionity Basic Information
15.26.2 Bionity Mumps Vaccine Product Overview
15.26.3 Bionity Mumps Vaccine Product Market Performance
15.26.4 Bionity Business Overview
15.26.5 Bionity Recent Developments
16 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Mumps Vaccine
1.2 Key Market Segments
1.2.1 Mumps Vaccine Segment by Type
1.2.2 Mumps Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL MUMPS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Mumps Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Mumps Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL MUMPS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Mumps Vaccine Product Life Cycle
3.3 Global Mumps Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Mumps Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Mumps Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Mumps Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Mumps Vaccine Market Competitive Situation and Trends
3.8.1 Mumps Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Mumps Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MUMPS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Mumps Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MUMPS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Mumps Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Mumps Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL MUMPS VACCINE MARKET BY REGION
6.1 Global Mumps Vaccine Market Size by Region
6.1.1 Global Mumps Vaccine Market Size by Region
6.1.2 Global Mumps Vaccine Market Size Market Share by Region
6.2 Global Mumps Vaccine Sales by Region
6.2.1 Global Mumps Vaccine Sales by Region
6.2.2 Global Mumps Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Mumps Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Mumps Vaccine Market Size by Type
7.3 North America Mumps Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Mumps Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Mumps Vaccine Market Size by Type
8.3 Europe Mumps Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Mumps Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Mumps Vaccine Market Size by Type
9.3 Asia-Pacific Mumps Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Mumps Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Mumps Vaccine Market Size by Type
10.3 South America Mumps Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Mumps Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Mumps Vaccine Market Size by Type
11.3 Middle East and Africa Mumps Vaccine Market Size by Application
12 MUMPS VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of Mumps Vaccine by Region(2020-2025)
12.2 Global Mumps Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Mumps Vaccine Production
12.4.1 North America Mumps Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Mumps Vaccine Production
12.5.1 Europe Mumps Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Mumps Vaccine Production (2020-2025)
12.6.1 Japan Mumps Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Mumps Vaccine Production (2020-2025)
12.7.1 China Mumps Vaccine Production Growth Rate (2020-2025)
12.7.2 China Mumps Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 MUMPS VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Mumps Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Mumps Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Mumps Vaccine Price by Type (2020-2033)
14 MUMPS VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Mumps Vaccine Market Sales by Application (2020-2033)
14.3 Global Mumps Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 MedImmune
15.1.1 MedImmune Basic Information
15.1.2 MedImmune Mumps Vaccine Product Overview
15.1.3 MedImmune Mumps Vaccine Product Market Performance
15.1.4 MedImmune Business Overview
15.1.5 MedImmune SWOT Analysis
15.1.6 MedImmune Recent Developments
15.2 Johnson and Johnson
15.2.1 Johnson and Johnson Basic Information
15.2.2 Johnson and Johnson Mumps Vaccine Product Overview
15.2.3 Johnson and Johnson Mumps Vaccine Product Market Performance
15.2.4 Johnson and Johnson Business Overview
15.2.5 Johnson and Johnson SWOT Analysis
15.2.6 Johnson and Johnson Recent Developments
15.3 Merck and Co.
15.3.1 Merck and Co. Basic Information
15.3.2 Merck and Co. Mumps Vaccine Product Overview
15.3.3 Merck and Co. Mumps Vaccine Product Market Performance
15.3.4 Merck and Co. Business Overview
15.3.5 Merck and Co. SWOT Analysis
15.3.6 Merck and Co. Recent Developments
15.4 Inc.
15.4.1 Inc. Basic Information
15.4.2 Inc. Mumps Vaccine Product Overview
15.4.3 Inc. Mumps Vaccine Product Market Performance
15.4.4 Inc. Business Overview
15.4.5 Inc. Recent Developments
15.5 Sanofi
15.5.1 Sanofi Basic Information
15.5.2 Sanofi Mumps Vaccine Product Overview
15.5.3 Sanofi Mumps Vaccine Product Market Performance
15.5.4 Sanofi Business Overview
15.5.5 Sanofi Recent Developments
15.6 Serum Institute of India
15.6.1 Serum Institute of India Basic Information
15.6.2 Serum Institute of India Mumps Vaccine Product Overview
15.6.3 Serum Institute of India Mumps Vaccine Product Market Performance
15.6.4 Serum Institute of India Business Overview
15.6.5 Serum Institute of India Recent Developments
15.7 Bavarian Nordic
15.7.1 Bavarian Nordic Basic Information
15.7.2 Bavarian Nordic Mumps Vaccine Product Overview
15.7.3 Bavarian Nordic Mumps Vaccine Product Market Performance
15.7.4 Bavarian Nordic Business Overview
15.7.5 Bavarian Nordic Recent Developments
15.8 Astellas Pharma India
15.8.1 Astellas Pharma India Basic Information
15.8.2 Astellas Pharma India Mumps Vaccine Product Overview
15.8.3 Astellas Pharma India Mumps Vaccine Product Market Performance
15.8.4 Astellas Pharma India Business Overview
15.8.5 Astellas Pharma India Recent Developments
15.9 CSL Limited
15.9.1 CSL Limited Basic Information
15.9.2 CSL Limited Mumps Vaccine Product Overview
15.9.3 CSL Limited Mumps Vaccine Product Market Performance
15.9.4 CSL Limited Business Overview
15.9.5 CSL Limited Recent Developments
15.10 Emergent BioSolutions
15.10.1 Emergent BioSolutions Basic Information
15.10.2 Emergent BioSolutions Mumps Vaccine Product Overview
15.10.3 Emergent BioSolutions Mumps Vaccine Product Market Performance
15.10.4 Emergent BioSolutions Business Overview
15.10.5 Emergent BioSolutions Recent Developments
15.11 GlaxoSmithKline
15.11.1 GlaxoSmithKline Basic Information
15.11.2 GlaxoSmithKline Mumps Vaccine Product Overview
15.11.3 GlaxoSmithKline Mumps Vaccine Product Market Performance
15.11.4 GlaxoSmithKline Business Overview
15.11.5 GlaxoSmithKline Recent Developments
15.12 Panacea Biotec
15.12.1 Panacea Biotec Basic Information
15.12.2 Panacea Biotec Mumps Vaccine Product Overview
15.12.3 Panacea Biotec Mumps Vaccine Product Market Performance
15.12.4 Panacea Biotec Business Overview
15.12.5 Panacea Biotec Recent Developments
15.13 Ltd.
15.13.1 Ltd. Basic Information
15.13.2 Ltd. Mumps Vaccine Product Overview
15.13.3 Ltd. Mumps Vaccine Product Market Performance
15.13.4 Ltd. Business Overview
15.13.5 Ltd. Recent Developments
15.14 Biological E Limited
15.14.1 Biological E Limited Basic Information
15.14.2 Biological E Limited Mumps Vaccine Product Overview
15.14.3 Biological E Limited Mumps Vaccine Product Market Performance
15.14.4 Biological E Limited Business Overview
15.14.5 Biological E Limited Recent Developments
15.15 Bharat Biotech Ltd.
15.15.1 Bharat Biotech Ltd. Basic Information
15.15.2 Bharat Biotech Ltd. Mumps Vaccine Product Overview
15.15.3 Bharat Biotech Ltd. Mumps Vaccine Product Market Performance
15.15.4 Bharat Biotech Ltd. Business Overview
15.15.5 Bharat Biotech Ltd. Recent Developments
15.16 Novavax
15.16.1 Novavax Basic Information
15.16.2 Novavax Mumps Vaccine Product Overview
15.16.3 Novavax Mumps Vaccine Product Market Performance
15.16.4 Novavax Business Overview
15.16.5 Novavax Recent Developments
15.17 Inc.
15.17.1 Inc. Basic Information
15.17.2 Inc. Mumps Vaccine Product Overview
15.17.3 Inc. Mumps Vaccine Product Market Performance
15.17.4 Inc. Business Overview
15.17.5 Inc. Recent Developments
15.18 Novartis
15.18.1 Novartis Basic Information
15.18.2 Novartis Mumps Vaccine Product Overview
15.18.3 Novartis Mumps Vaccine Product Market Performance
15.18.4 Novartis Business Overview
15.18.5 Novartis Recent Developments
15.19 Sinovac Biotech
15.19.1 Sinovac Biotech Basic Information
15.19.2 Sinovac Biotech Mumps Vaccine Product Overview
15.19.3 Sinovac Biotech Mumps Vaccine Product Market Performance
15.19.4 Sinovac Biotech Business Overview
15.19.5 Sinovac Biotech Recent Developments
15.20 Ltd.
15.20.1 Ltd. Basic Information
15.20.2 Ltd. Mumps Vaccine Product Overview
15.20.3 Ltd. Mumps Vaccine Product Market Performance
15.20.4 Ltd. Business Overview
15.20.5 Ltd. Recent Developments
15.21 Incepta Vaccine Limited
15.21.1 Incepta Vaccine Limited Basic Information
15.21.2 Incepta Vaccine Limited Mumps Vaccine Product Overview
15.21.3 Incepta Vaccine Limited Mumps Vaccine Product Market Performance
15.21.4 Incepta Vaccine Limited Business Overview
15.21.5 Incepta Vaccine Limited Recent Developments
15.22 Valneva SE
15.22.1 Valneva SE Basic Information
15.22.2 Valneva SE Mumps Vaccine Product Overview
15.22.3 Valneva SE Mumps Vaccine Product Market Performance
15.22.4 Valneva SE Business Overview
15.22.5 Valneva SE Recent Developments
15.23 VBI Vaccines
15.23.1 VBI Vaccines Basic Information
15.23.2 VBI Vaccines Mumps Vaccine Product Overview
15.23.3 VBI Vaccines Mumps Vaccine Product Market Performance
15.23.4 VBI Vaccines Business Overview
15.23.5 VBI Vaccines Recent Developments
15.24 PT Bio Farma
15.24.1 PT Bio Farma Basic Information
15.24.2 PT Bio Farma Mumps Vaccine Product Overview
15.24.3 PT Bio Farma Mumps Vaccine Product Market Performance
15.24.4 PT Bio Farma Business Overview
15.24.5 PT Bio Farma Recent Developments
15.25 Sharp and Dohme Corp
15.25.1 Sharp and Dohme Corp Basic Information
15.25.2 Sharp and Dohme Corp Mumps Vaccine Product Overview
15.25.3 Sharp and Dohme Corp Mumps Vaccine Product Market Performance
15.25.4 Sharp and Dohme Corp Business Overview
15.25.5 Sharp and Dohme Corp Recent Developments
15.26 Bionity
15.26.1 Bionity Basic Information
15.26.2 Bionity Mumps Vaccine Product Overview
15.26.3 Bionity Mumps Vaccine Product Market Performance
15.26.4 Bionity Business Overview
15.26.5 Bionity Recent Developments
16 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mumps Vaccine Market Size by Type (M USD)
Table 4. Global Mumps Vaccine Market Size by Application (M USD)
Table 5. Mumps Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Mumps Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Mumps Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mumps Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mumps Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Vaccine as of 2024)
Table 11. Global Market Mumps Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Mumps Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Mumps Vaccine Product Type
Table 14. Global Mumps Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mumps Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Mumps Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Mumps Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Mumps Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Mumps Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Mumps Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Mumps Vaccine Sales by Type (K MT)
Table 33. North America Mumps Vaccine Market Size by Type (M USD)
Table 34. North America Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Mumps Vaccine Sales by Application (K MT)
Table 37. North America Mumps Vaccine Market Size by Application (M USD)
Table 38. North America Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Mumps Vaccine Sales by Type (K MT)
Table 43. Europe Mumps Vaccine Market Size by Type (M USD)
Table 44. Europe Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Mumps Vaccine Sales by Application (K MT)
Table 47. Europe Mumps Vaccine Market Size by Application (M USD)
Table 48. Europe Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Mumps Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Mumps Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Mumps Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Mumps Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Mumps Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Mumps Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Mumps Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Mumps Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Mumps Vaccine Sales by Type (K MT)
Table 63. South America Mumps Vaccine Market Size by Type (M USD)
Table 64. South America Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Mumps Vaccine Sales by Application (K MT)
Table 67. South America Mumps Vaccine Market Size by Application (M USD)
Table 68. South America Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Mumps Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Mumps Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Mumps Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Mumps Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Mumps Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Mumps Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Mumps Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Mumps Vaccine Sales by Type (K MT)
Table 89. Global Mumps Vaccine Market Size by Type (M USD)
Table 90. Global Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Mumps Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Mumps Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Mumps Vaccine Sales (K MT) by Application
Table 95. Global Mumps Vaccine Market Size by Application(M USD)
Table 96. Global Mumps Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Mumps Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Mumps Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Mumps Vaccine Market Share by Application (2020-2033)
Table 100. Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. MedImmune Basic Information
Table 102. MedImmune Mumps Vaccine Product Overview
Table 103. MedImmune Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. MedImmune Business Overview
Table 105. MedImmune SWOT Analysis
Table 106. MedImmune Recent Developments
Table 107. Johnson and Johnson Basic Information
Table 108. Johnson and Johnson Mumps Vaccine Product Overview
Table 109. Johnson and Johnson Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Johnson and Johnson Business Overview
Table 111. Johnson and Johnson SWOT Analysis
Table 112. Johnson and Johnson Recent Developments
Table 113. Merck and Co. Basic Information
Table 114. Merck and Co. Mumps Vaccine Product Overview
Table 115. Merck and Co. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Merck and Co. Business Overview
Table 117. Merck and Co. SWOT Analysis
Table 118. Merck and Co. Recent Developments
Table 119. Inc. Basic Information
Table 120. Inc. Mumps Vaccine Product Overview
Table 121. Inc. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Inc. Business Overview
Table 123. Inc. Recent Developments
Table 124. Sanofi Basic Information
Table 125. Sanofi Mumps Vaccine Product Overview
Table 126. Sanofi Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Sanofi Business Overview
Table 128. Sanofi Recent Developments
Table 129. Serum Institute of India Basic Information
Table 130. Serum Institute of India Mumps Vaccine Product Overview
Table 131. Serum Institute of India Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Serum Institute of India Business Overview
Table 133. Serum Institute of India Recent Developments
Table 134. Bavarian Nordic Basic Information
Table 135. Bavarian Nordic Mumps Vaccine Product Overview
Table 136. Bavarian Nordic Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Bavarian Nordic Business Overview
Table 138. Bavarian Nordic Recent Developments
Table 139. Astellas Pharma India Basic Information
Table 140. Astellas Pharma India Mumps Vaccine Product Overview
Table 141. Astellas Pharma India Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Astellas Pharma India Business Overview
Table 143. Astellas Pharma India Recent Developments
Table 144. CSL Limited Basic Information
Table 145. CSL Limited Mumps Vaccine Product Overview
Table 146. CSL Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. CSL Limited Business Overview
Table 148. CSL Limited Recent Developments
Table 149. Emergent BioSolutions Basic Information
Table 150. Emergent BioSolutions Mumps Vaccine Product Overview
Table 151. Emergent BioSolutions Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Emergent BioSolutions Business Overview
Table 153. Emergent BioSolutions Recent Developments
Table 154. GlaxoSmithKline Basic Information
Table 155. GlaxoSmithKline Mumps Vaccine Product Overview
Table 156. GlaxoSmithKline Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. GlaxoSmithKline Business Overview
Table 158. GlaxoSmithKline Recent Developments
Table 159. Panacea Biotec Basic Information
Table 160. Panacea Biotec Mumps Vaccine Product Overview
Table 161. Panacea Biotec Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Panacea Biotec Business Overview
Table 163. Panacea Biotec Recent Developments
Table 164. Ltd. Basic Information
Table 165. Ltd. Mumps Vaccine Product Overview
Table 166. Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Ltd. Business Overview
Table 168. Ltd. Recent Developments
Table 169. Biological E Limited Basic Information
Table 170. Biological E Limited Mumps Vaccine Product Overview
Table 171. Biological E Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Biological E Limited Business Overview
Table 173. Biological E Limited Recent Developments
Table 174. Bharat Biotech Ltd. Basic Information
Table 175. Bharat Biotech Ltd. Mumps Vaccine Product Overview
Table 176. Bharat Biotech Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Bharat Biotech Ltd. Business Overview
Table 178. Bharat Biotech Ltd. Recent Developments
Table 179. Novavax Basic Information
Table 180. Novavax Mumps Vaccine Product Overview
Table 181. Novavax Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Novavax Business Overview
Table 183. Novavax Recent Developments
Table 184. Inc. Basic Information
Table 185. Inc. Mumps Vaccine Product Overview
Table 186. Inc. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Inc. Business Overview
Table 188. Inc. Recent Developments
Table 189. Novartis Basic Information
Table 190. Novartis Mumps Vaccine Product Overview
Table 191. Novartis Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Novartis Business Overview
Table 193. Novartis Recent Developments
Table 194. Sinovac Biotech Basic Information
Table 195. Sinovac Biotech Mumps Vaccine Product Overview
Table 196. Sinovac Biotech Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Sinovac Biotech Business Overview
Table 198. Sinovac Biotech Recent Developments
Table 199. Ltd. Basic Information
Table 200. Ltd. Mumps Vaccine Product Overview
Table 201. Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Ltd. Business Overview
Table 203. Ltd. Recent Developments
Table 204. Incepta Vaccine Limited Basic Information
Table 205. Incepta Vaccine Limited Mumps Vaccine Product Overview
Table 206. Incepta Vaccine Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Incepta Vaccine Limited Business Overview
Table 208. Incepta Vaccine Limited Recent Developments
Table 209. Valneva SE Basic Information
Table 210. Valneva SE Mumps Vaccine Product Overview
Table 211. Valneva SE Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. Valneva SE Business Overview
Table 213. Valneva SE Recent Developments
Table 214. VBI Vaccines Basic Information
Table 215. VBI Vaccines Mumps Vaccine Product Overview
Table 216. VBI Vaccines Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 217. VBI Vaccines Business Overview
Table 218. VBI Vaccines Recent Developments
Table 219. PT Bio Farma Basic Information
Table 220. PT Bio Farma Mumps Vaccine Product Overview
Table 221. PT Bio Farma Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 222. PT Bio Farma Business Overview
Table 223. PT Bio Farma Recent Developments
Table 224. Sharp and Dohme Corp Basic Information
Table 225. Sharp and Dohme Corp Mumps Vaccine Product Overview
Table 226. Sharp and Dohme Corp Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 227. Sharp and Dohme Corp Business Overview
Table 228. Sharp and Dohme Corp Recent Developments
Table 229. Bionity Basic Information
Table 230. Bionity Mumps Vaccine Product Overview
Table 231. Bionity Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 232. Bionity Business Overview
Table 233. Bionity Recent Developments
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Mumps Vaccine Market Size by Type (M USD)
Table 4. Global Mumps Vaccine Market Size by Application (M USD)
Table 5. Mumps Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Mumps Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Mumps Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Mumps Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Mumps Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Vaccine as of 2024)
Table 11. Global Market Mumps Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Mumps Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Mumps Vaccine Product Type
Table 14. Global Mumps Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mumps Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Mumps Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Mumps Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Mumps Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Mumps Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Mumps Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Mumps Vaccine Sales by Type (K MT)
Table 33. North America Mumps Vaccine Market Size by Type (M USD)
Table 34. North America Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Mumps Vaccine Sales by Application (K MT)
Table 37. North America Mumps Vaccine Market Size by Application (M USD)
Table 38. North America Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Mumps Vaccine Sales by Type (K MT)
Table 43. Europe Mumps Vaccine Market Size by Type (M USD)
Table 44. Europe Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Mumps Vaccine Sales by Application (K MT)
Table 47. Europe Mumps Vaccine Market Size by Application (M USD)
Table 48. Europe Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Mumps Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Mumps Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Mumps Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Mumps Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Mumps Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Mumps Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Mumps Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Mumps Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Mumps Vaccine Sales by Type (K MT)
Table 63. South America Mumps Vaccine Market Size by Type (M USD)
Table 64. South America Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Mumps Vaccine Sales by Application (K MT)
Table 67. South America Mumps Vaccine Market Size by Application (M USD)
Table 68. South America Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Mumps Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Mumps Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Mumps Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Mumps Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Mumps Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Mumps Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Mumps Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Mumps Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Mumps Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Mumps Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Mumps Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Mumps Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Mumps Vaccine Sales by Type (K MT)
Table 89. Global Mumps Vaccine Market Size by Type (M USD)
Table 90. Global Mumps Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Mumps Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Mumps Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Mumps Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Mumps Vaccine Sales (K MT) by Application
Table 95. Global Mumps Vaccine Market Size by Application(M USD)
Table 96. Global Mumps Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Mumps Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Mumps Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Mumps Vaccine Market Share by Application (2020-2033)
Table 100. Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. MedImmune Basic Information
Table 102. MedImmune Mumps Vaccine Product Overview
Table 103. MedImmune Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. MedImmune Business Overview
Table 105. MedImmune SWOT Analysis
Table 106. MedImmune Recent Developments
Table 107. Johnson and Johnson Basic Information
Table 108. Johnson and Johnson Mumps Vaccine Product Overview
Table 109. Johnson and Johnson Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Johnson and Johnson Business Overview
Table 111. Johnson and Johnson SWOT Analysis
Table 112. Johnson and Johnson Recent Developments
Table 113. Merck and Co. Basic Information
Table 114. Merck and Co. Mumps Vaccine Product Overview
Table 115. Merck and Co. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Merck and Co. Business Overview
Table 117. Merck and Co. SWOT Analysis
Table 118. Merck and Co. Recent Developments
Table 119. Inc. Basic Information
Table 120. Inc. Mumps Vaccine Product Overview
Table 121. Inc. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Inc. Business Overview
Table 123. Inc. Recent Developments
Table 124. Sanofi Basic Information
Table 125. Sanofi Mumps Vaccine Product Overview
Table 126. Sanofi Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Sanofi Business Overview
Table 128. Sanofi Recent Developments
Table 129. Serum Institute of India Basic Information
Table 130. Serum Institute of India Mumps Vaccine Product Overview
Table 131. Serum Institute of India Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Serum Institute of India Business Overview
Table 133. Serum Institute of India Recent Developments
Table 134. Bavarian Nordic Basic Information
Table 135. Bavarian Nordic Mumps Vaccine Product Overview
Table 136. Bavarian Nordic Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Bavarian Nordic Business Overview
Table 138. Bavarian Nordic Recent Developments
Table 139. Astellas Pharma India Basic Information
Table 140. Astellas Pharma India Mumps Vaccine Product Overview
Table 141. Astellas Pharma India Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Astellas Pharma India Business Overview
Table 143. Astellas Pharma India Recent Developments
Table 144. CSL Limited Basic Information
Table 145. CSL Limited Mumps Vaccine Product Overview
Table 146. CSL Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. CSL Limited Business Overview
Table 148. CSL Limited Recent Developments
Table 149. Emergent BioSolutions Basic Information
Table 150. Emergent BioSolutions Mumps Vaccine Product Overview
Table 151. Emergent BioSolutions Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Emergent BioSolutions Business Overview
Table 153. Emergent BioSolutions Recent Developments
Table 154. GlaxoSmithKline Basic Information
Table 155. GlaxoSmithKline Mumps Vaccine Product Overview
Table 156. GlaxoSmithKline Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. GlaxoSmithKline Business Overview
Table 158. GlaxoSmithKline Recent Developments
Table 159. Panacea Biotec Basic Information
Table 160. Panacea Biotec Mumps Vaccine Product Overview
Table 161. Panacea Biotec Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Panacea Biotec Business Overview
Table 163. Panacea Biotec Recent Developments
Table 164. Ltd. Basic Information
Table 165. Ltd. Mumps Vaccine Product Overview
Table 166. Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Ltd. Business Overview
Table 168. Ltd. Recent Developments
Table 169. Biological E Limited Basic Information
Table 170. Biological E Limited Mumps Vaccine Product Overview
Table 171. Biological E Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Biological E Limited Business Overview
Table 173. Biological E Limited Recent Developments
Table 174. Bharat Biotech Ltd. Basic Information
Table 175. Bharat Biotech Ltd. Mumps Vaccine Product Overview
Table 176. Bharat Biotech Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Bharat Biotech Ltd. Business Overview
Table 178. Bharat Biotech Ltd. Recent Developments
Table 179. Novavax Basic Information
Table 180. Novavax Mumps Vaccine Product Overview
Table 181. Novavax Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Novavax Business Overview
Table 183. Novavax Recent Developments
Table 184. Inc. Basic Information
Table 185. Inc. Mumps Vaccine Product Overview
Table 186. Inc. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Inc. Business Overview
Table 188. Inc. Recent Developments
Table 189. Novartis Basic Information
Table 190. Novartis Mumps Vaccine Product Overview
Table 191. Novartis Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Novartis Business Overview
Table 193. Novartis Recent Developments
Table 194. Sinovac Biotech Basic Information
Table 195. Sinovac Biotech Mumps Vaccine Product Overview
Table 196. Sinovac Biotech Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Sinovac Biotech Business Overview
Table 198. Sinovac Biotech Recent Developments
Table 199. Ltd. Basic Information
Table 200. Ltd. Mumps Vaccine Product Overview
Table 201. Ltd. Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Ltd. Business Overview
Table 203. Ltd. Recent Developments
Table 204. Incepta Vaccine Limited Basic Information
Table 205. Incepta Vaccine Limited Mumps Vaccine Product Overview
Table 206. Incepta Vaccine Limited Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Incepta Vaccine Limited Business Overview
Table 208. Incepta Vaccine Limited Recent Developments
Table 209. Valneva SE Basic Information
Table 210. Valneva SE Mumps Vaccine Product Overview
Table 211. Valneva SE Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 212. Valneva SE Business Overview
Table 213. Valneva SE Recent Developments
Table 214. VBI Vaccines Basic Information
Table 215. VBI Vaccines Mumps Vaccine Product Overview
Table 216. VBI Vaccines Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 217. VBI Vaccines Business Overview
Table 218. VBI Vaccines Recent Developments
Table 219. PT Bio Farma Basic Information
Table 220. PT Bio Farma Mumps Vaccine Product Overview
Table 221. PT Bio Farma Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 222. PT Bio Farma Business Overview
Table 223. PT Bio Farma Recent Developments
Table 224. Sharp and Dohme Corp Basic Information
Table 225. Sharp and Dohme Corp Mumps Vaccine Product Overview
Table 226. Sharp and Dohme Corp Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 227. Sharp and Dohme Corp Business Overview
Table 228. Sharp and Dohme Corp Recent Developments
Table 229. Bionity Basic Information
Table 230. Bionity Mumps Vaccine Product Overview
Table 231. Bionity Mumps Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 232. Bionity Business Overview
Table 233. Bionity Recent Developments
LIST OF FIGURES
Figure 1. Product Picture of Mumps Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mumps Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Mumps Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Mumps Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mumps Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mumps Vaccine Product Life Cycle
Figure 13. Mumps Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Mumps Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Mumps Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mumps Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Mumps Vaccine
Figure 19. Global Mumps Vaccine Market PEST Analysis
Figure 20. Global Mumps Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Mumps Vaccine Market Size by Region
Figure 27. Global Mumps Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Mumps Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Mumps Vaccine Market Size (M USD) by Country
Figure 33. USA Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Mumps Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Mumps Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Mumps Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Mumps Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Mumps Vaccine Market Size (M USD)by Type
Figure 40. North America Mumps Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Mumps Vaccine Market Size (M USD) by Country
Figure 45. Germany Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Mumps Vaccine Market Size (M USD) by Type
Figure 56. Europe Mumps Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Mumps Vaccine Market Size (M USD) by Country
Figure 61. China Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Mumps Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Mumps Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Mumps Vaccine Market Size (M USD) by Country
Figure 77. Brazil Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Mumps Vaccine Market Size (M USD) by Type
Figure 84. South America Mumps Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Mumps Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Mumps Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Mumps Vaccine Market Size (M USD) by Application
Figure 101. Global Mumps Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Mumps Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Mumps Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Mumps Vaccine by Type in 2024
Figure 110. Market Size Share of Mumps Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Mumps Vaccine by Type in 2024
Figure 112. Global Mumps Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Mumps Vaccine Market Size by Application(M USD)
Figure 115. Global Mumps Vaccine Market Share by Application
Figure 116. Global Mumps Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Mumps Vaccine Sales Market Share by Application in 2024
Figure 118. Global Mumps Vaccine Market Share by Application (2020-2033)
Figure 119. Global Mumps Vaccine Market Share by Application in 2024
Figure 120. Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
Figure 1. Product Picture of Mumps Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mumps Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Mumps Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Mumps Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mumps Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Mumps Vaccine Product Life Cycle
Figure 13. Mumps Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Mumps Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Mumps Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Mumps Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Mumps Vaccine
Figure 19. Global Mumps Vaccine Market PEST Analysis
Figure 20. Global Mumps Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Mumps Vaccine Market Size by Region
Figure 27. Global Mumps Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Mumps Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Mumps Vaccine Market Size (M USD) by Country
Figure 33. USA Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Mumps Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Mumps Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Mumps Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Mumps Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Mumps Vaccine Market Size (M USD)by Type
Figure 40. North America Mumps Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Mumps Vaccine Market Size (M USD) by Country
Figure 45. Germany Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Mumps Vaccine Market Size (M USD) by Type
Figure 56. Europe Mumps Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Mumps Vaccine Market Size (M USD) by Country
Figure 61. China Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Mumps Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Mumps Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Mumps Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Mumps Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Mumps Vaccine Market Size (M USD) by Country
Figure 77. Brazil Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Mumps Vaccine Market Size (M USD) by Type
Figure 84. South America Mumps Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Mumps Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Mumps Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Mumps Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Mumps Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Mumps Vaccine Market Size (M USD) by Application
Figure 101. Global Mumps Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Mumps Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Mumps Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Mumps Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Mumps Vaccine by Type in 2024
Figure 110. Market Size Share of Mumps Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Mumps Vaccine by Type in 2024
Figure 112. Global Mumps Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Mumps Vaccine Market Size by Application(M USD)
Figure 115. Global Mumps Vaccine Market Share by Application
Figure 116. Global Mumps Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Mumps Vaccine Sales Market Share by Application in 2024
Figure 118. Global Mumps Vaccine Market Share by Application (2020-2033)
Figure 119. Global Mumps Vaccine Market Share by Application in 2024
Figure 120. Global Mumps Vaccine Sales Growth Rate by Application (2020-2033)
